April 8, 2015
Pres. Brunn shows his first Japanese calligraphy work written “Innovation” Bayer Yakuhin notched up double-digit growth for the second consecutive year in 2014, driven by the anticoagulant Xarelto (rivaroxaban) and other major products, and it aspires to keep this momentum...read more